Stay updated on Long-term Safety of Inovelon in Lennox-Gastaut Syndrome Clinical Trial
Sign up to get notified when there's something new on the Long-term Safety of Inovelon in Lennox-Gastaut Syndrome Clinical Trial page.

Latest updates to the Long-term Safety of Inovelon in Lennox-Gastaut Syndrome Clinical Trial page
- CheckyesterdayChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check8 days agoChange DetectedA sitewide NIH banner announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology. The clinical trial record itself remains inaccessible and displays a 403 error.SummaryDifference1%

- Check15 days agoChange DetectedThe footer’s site revision label changes from v3.7.1 to v3.7.2, while the study record remains an inaccessible 403 error page.SummaryDifference0.2%

- Check22 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1 on the 403 Forbidden page.SummaryDifference0.2%

- Check43 days agoChange DetectedThe study record page now displays a 403 Forbidden error, replacing the detailed study information with an access-denied message.SummaryDifference15%

- Check64 days agoChange DetectedThe revision label updated from v3.6.5 to v3.6.6, signaling a small site update without changes to the study information.SummaryDifference0.1%

Stay in the know with updates to Long-term Safety of Inovelon in Lennox-Gastaut Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-term Safety of Inovelon in Lennox-Gastaut Syndrome Clinical Trial page.